TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Stock
Certificat
DE000SU7BBY4
| Market Closed - Boerse Frankfurt Warrants 03:36:38 2024-07-12 pm EDT | ||
| 35.44 EUR | +0.17% |
|
| Current month | -6.22% | ||
| 1 month | -4.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 35.3 | -0.23% |
| 24-07-11 | 35.38 | -0.53% |
| 24-07-10 | 35.57 | -1.11% |
| 24-07-09 | 35.97 | -0.94% |
| 24-07-08 | 36.31 | -1.86% |
Real-time Boerse Frankfurt Warrants
Last update July 12, 2024 at 03:36 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SU7BBY |
| ISIN | DE000SU7BBY4 |
| Date issued | 2024-01-23 |
| Strike | 873.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 40.22 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 45.23 € |
|---|---|
| Lowest since issue | 34.7 € |
| Spread | 0.05 € |
| Spread % | 0.14% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
488.7
USD
Average target price
473.1
USD
Spread / Average Target
-3.20%
- Stock Market
- Certificates
- Certificat
